Cargando…
Real World Evidence and Clinical Utility of KidneyIntelX on Patients With Early-Stage Diabetic Kidney Disease: Interim Results on Decision Impact and Outcomes
INTRODUCTION AND OBJECTIVE: The lack of precision to identify patients with early-stage diabetic kidney disease (DKD) at near-term risk for progressive decline in kidney function results in poor disease management often leading to kidney failure requiring unplanned dialysis. The KidneyIntelX is a mu...
Autores principales: | Tokita, Joji, Vega, Aida, Sinfield, Catherine, Naik, Nidhi, Rathi, Shivani, Martin, Sharlene, Wang, Stephanie, Amoruso, Leonard, Zabetian, Azadeh, Coca, Steven G., Nadkarni, Girish N., Fleming, Fergus, Donovan, Michael J., Fields, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677284/ https://www.ncbi.nlm.nih.gov/pubmed/36404761 http://dx.doi.org/10.1177/21501319221138196 |
Ejemplares similares
-
Plasma and urine biomarkers in chronic kidney disease: closer to clinical application
por: Zabetian, Azadeh, et al.
Publicado: (2021) -
Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease
por: Chan, Lili, et al.
Publicado: (2021) -
Intel and ML
por: Pabst, Hans
Publicado: (2017) -
Intel and Healthcare
por: Dr. SAWLEY, Marie-Christine
Publicado: (2014) -
INTEL: Intel based systems move up in supercomputing ranks
Publicado: (2002)